We have previously demonstrated that gene defects perturbing the major CNS myelin proteolipid protein (PLP) - implicated in leukodystrophy and multiple sclerosis - result in neuroinflammation which amplifies neural damage and represents a target for treatment strategies19. The gene discussed is PLP1; the disease is leukodystrophy.